Hologic Taken Private by Blackstone and TPG for Up to $79

Blackstone and TPG have completed their acquisition of Hologic, taking the women’s health medical device company private. The transaction is valued at up to $79 per share, consisting of $76 per share in cash plus a non-tradable contingent value right (CVR) that can pay up to $3 per share.

The CVR is tied to achievement of global revenue goals for Hologic’s Breast Health business in fiscal years 2026 and 2027, paid in up to two installments of up to $1.50 each. Hologic stockholders approved the deal on February 5, 2026, and the company has appointed José (Joe) E. Almeida as CEO effective immediately. Hologic’s common stock has ceased trading and will be delisted from Nasdaq.